Chronic Myeloproliferative Disorders Completed Phase 3 Trials for Morphine (DB00295)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003687Treatment for Chronic Pain in Patients With Advanced CancerSupportive Care